Blog
RSS FeedPosted by Michael Wonder on 17 May 2017
Coalition calls on CADTH to balance scales and fix system
10 May 2017 - Canada's advocacy coalition for people living with depression says CADTH has an opportunity, right now, to ...
Posted by Michael Wonder on 25 Apr 2017
CADTH symposium examines tough questions about assessing value in health care
23 April 2017 - As health care spending continues to grow, the need to derive maximum value from every health ...
Posted by Michael Wonder on 20 Apr 2017
CADTH recommends Kevzara
18 April 2017 - Sarilumab was approved by Health Canada on 12 Jan 2017 for the treatment of adult patients ...
Posted by Michael Wonder on 17 Apr 2017
Expanding CADTH’s drug review processes to include radiopharmaceuticals
17 April 2017 - In collaboration with the participating jurisdictions, CADTH is pleased to announce that it will accept submissions ...
Posted by Michael Wonder on 06 Apr 2017
CADTH symposium promotes the use of evidence in health care
6 April 2017 - From April 10 to 12, 2016, health care experts from across Canada and around the world ...
Posted by Michael Wonder on 27 Mar 2017
CADTH recommends Teva's Cinqair
22 March 2017 - Recommendation states price needs to be reduced by 90%. ...
Posted by Michael Wonder on 23 Mar 2017
CADTH recommends reimbursement of Stelara for new indication
21 March 2017 - The cost of treatment with ustekinumab should not exceed the drug plan cost of the least costly ...
Posted by Michael Wonder on 21 Mar 2017
Launch of new Canadian Guidelines for the Economic Evaluation of Health Technologies
21 March 2017 - This release marks the first update to the Guidelines since the third edition was published in ...
Posted by Michael Wonder on 16 Mar 2017
Call for feedback: new drugs for type 2 diabetes: second-line therapy : a therapeutic review update
15 March 2017 - A report on new drugs for second-line therapy for 2 diabetes: a therapeutic review update is now ...
Posted by Michael Wonder on 15 Mar 2017
New CADTH guidelines for the economic evaluation of health technologies
15 March 2017 - Join CADTH in person or online on Tuesday, 28 March 2017 as they release the fourth ...
Posted by Michael Wonder on 30 Jan 2017
CADTH recommends UCB's Brivlera
25 January 2017 - CADTH's first outcome for 2017 is in favour of the reimbursement of brivaracetam. ...
Posted by Michael Wonder on 22 Jan 2017
Call for feedback on a therapeutic review update of new second-line therapies for type 2 diabetes mellitus
20 January 2017 - Two draft science reports on new drugs for type 2 diabetes: second-line therapy : a therapeutic review ...
Posted by Michael Wonder on 19 Jan 2017
CADTH style guide
19 January 2017 - This fifth edition of the CADTH Style Guide provides the most current style and language usage ...
Posted by Michael Wonder on 08 Dec 2016
Single drug technology assessment processes across Health Technology Assessment organisations
8 December 2016 - Health Technology Assessment (HTA) informs health care decision-makers about the value — such as the safety, efficacy, ...
Posted by Michael Wonder on 25 Nov 2016
CADTH calls for input on submission for new medicine for patients with biliary cirrhosis
24 November 2016 - CADTH is calling for patient input on a pending submission from Intercept Pharmaceuticals for obeticholic acid. ...